Evaluation of alfaxalone total intravenous anesthesia in rabbits (Oryctolagus cuniculus) premedicated with dexmedetomidine or dexmedetomidine and buprenorphine. (May 2022)

• Record Type: Journal Article
• Authors: Bradley, Michael P.; Doerning, Carolyn M.; Nowland, Megan H.; Pasloske, Kirby; Lester, Patrick A.
• Is Part Of: Veterinary anaesthesia and analgesia. Volume 49:Number 3(2022)
• Page Start: 308
• Page End: 312
• Publication Date: 2022-05
• Subjects: alfaxalone -- anesthesia -- buprenorphine -- dexmedetomidine -- rabbit -- TIVA; Veterinary anesthesia -- Periodicals; 636.089
• DOI: 10.1016/j.vaa.2022.01.006
• Languages: English
• ISSNs: 1467-2987

Abstract

Abstract: Objective: To evaluate alfaxalone for total intravenous anesthesia (TIVA) in rabbits premedicated with dexmedetomidine or dexmedetomidine and buprenorphine. Study design: Crossover study (part 1) with observational study (part 2). Animals: A total of eight New Zealand White rabbits ( Oryctolagus cunicul us ), four female and four male, aged 12–16 weeks and weighing 2.8–3.5 kg in part 1. Separately, four additional rabbits in part 2. Methods: Crossover study design with eight rabbits per treatment. Rabbits were administered treatment D, dexmedetomidine (0.2 mg kg –1 ), or treatment DB, dexmedetomidine (0.1 mg kg –1 ) and buprenorphine (0.05 mg kg –1 ) intramuscularly. Anesthesia was induced with alfaxalone intravenously until a supraglottic airway device was placed to deliver 100% oxygen. Anesthesia was maintained with alfaxalone (TIVA). Infusion rates were adjusted to achieve an absent pedal withdrawal reflex. Heart rate, respiratory rate, noninvasive blood pressure, end-tidal carbon dioxide partial pressure and peripheral hemoglobin oxygen saturation (SpO2 ) were recorded every 5 minutes. Subsequently, four rabbits underwent ovariohysterectomy using treatment DB and alfaxalone TIVA. Results: The mean ± standard deviation alfaxalone infusion rate was 9.6 ± 2.6 and 4.5 ± 1.3 mg kg –1 hour –1 for treatments D and DB, respectively. In both treatments, blood pressure remained within acceptable range and SpO2 was > 95%. Postinduction apnea and respiratory depression were observed in both treatments and managed with manual positive pressure ventilation. Four separate rabbits underwent successful ovariohysterectomy with treatment DB and alfaxalone TIVA. One rabbit required supplementation with inhalant anesthesia; three rabbits were successfully maintained using alfaxalone TIVA alone. Conclusions and clinical relevance: Premedication with dexmedetomidine–buprenorphine combined with alfaxalone TIVA may be a viable alternative for performing abdominal surgery in the rabbit. The use of supplemental oxygen and ability to provide respiratory support are advised.